GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amgen Inc (BSP:AMGN34) » Definitions » 5-Year Yield-on-Cost %

Amgen (BSP:AMGN34) 5-Year Yield-on-Cost % : 3.83 (As of Apr. 25, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Amgen 5-Year Yield-on-Cost %?

Amgen's yield on cost for the quarter that ended in Dec. 2023 was 3.83.


The historical rank and industry rank for Amgen's 5-Year Yield-on-Cost % or its related term are showing as below:

BSP:AMGN34' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 2.18   Med: 4.16   Max: 6.02
Current: 3.83


During the past 13 years, Amgen's highest Yield on Cost was 6.02. The lowest was 2.18. And the median was 4.16.


BSP:AMGN34's 5-Year Yield-on-Cost % is ranked better than
79.56% of 499 companies
in the Drug Manufacturers industry
Industry Median: 2.24 vs BSP:AMGN34: 3.83

Competitive Comparison of Amgen's 5-Year Yield-on-Cost %

For the Drug Manufacturers - General subindustry, Amgen's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amgen's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amgen's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Amgen's 5-Year Yield-on-Cost % falls into.



Amgen 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Amgen is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Amgen  (BSP:AMGN34) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Amgen 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Amgen's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Amgen (BSP:AMGN34) Business Description

Address
One Amgen Center Drive, Thousand Oaks, CA, USA, 91320-1799
Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brings several rare disease drugs, including thyroid eye disease drug Tepezza. Amgen also has a growing biosimilar portfolio.

Amgen (BSP:AMGN34) Headlines

No Headlines